| Vardenafil-induced generalized urticaria. | |
| | |
MedLine Citation:
|
PMID: 15482393 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Vardenafil is a potent selective and reversible inhibitor of the cGMP phosphodiesterase type 5 that has been shown to improve erectile function in men. Vardenafil is usually well tolerated; the most common adverse events are headache, flushing, rhinitis, sinusitis and dyspepsia. We report a case of a 48-year-old man with an acute episode of widespread urticaria following vardenafil consumption and in absence of other identifiable causative factors. The patient had no previous episodes of urticaria. This appears to be the first report of urticaria associated with vardenafil. |
| | |
Authors:
|
P L Minciullo; A Saija; M Patafi; L Giannetto; G Marotta; B Ferlazzo; S Gangemi |
Related Documents
:
|
15997423 - Osteoporosis in hfe2 juvenile hemochromatosis. a case report and review of the literature. 3447073 - Pleomorphic xanthoastrocytoma in a 62-year-old male. 12625893 - An unusual pattern of intubation injury? |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of clinical pharmacy and therapeutics Volume: 29 ISSN: 0269-4727 ISO Abbreviation: J Clin Pharm Ther Publication Date: 2004 Oct |
Date Detail:
|
Created Date: 2004-10-14 Completed Date: 2005-01-14 Revised Date: 2008-05-28 |
Medline Journal Info:
|
Nlm Unique ID: 8704308 Medline TA: J Clin Pharm Ther Country: England |
Other Details:
|
Languages: eng Pagination: 483-4 Citation Subset: IM |
Affiliation:
|
Department of Human Pathology, Division and School of Allergy and Clinical Immunology, University of Messina, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Erectile Dysfunction
/
drug therapy Humans Imidazoles / adverse effects*, therapeutic use Male Middle Aged Phosphodiesterase Inhibitors / adverse effects*, therapeutic use Piperazines / adverse effects*, therapeutic use Sulfones Triazines Urticaria / chemically induced* |
| Chemical | |
Reg. No./Substance:
|
0/Imidazoles; 0/Phosphodiesterase Inhibitors; 0/Piperazines; 0/Sulfones; 0/Triazines; 224785-90-4/vardenafil |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Initiation of atypical antipsychotic agents and health outcomes in patients with schizophrenia.
Next Document: Unusual hypersensitivity to warfarin in a critically ill patient.